Epocrates

Epocrates FY 2012: net loss $3.4M; diluted EPS −$0.14

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Epocrates reported for the year ended Dec 31, 2012, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$3.4MAgainst −$3.6M in FY 201110-K income statement, on EDGAR
  2. Diluted EPS−$0.14Against −$0.17 in FY 201110-K income statement, on EDGAR
  3. Cash and cash equivalents$58.9M−22% from $75.3M in FY 2011Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  4. Cash from operations−$4.6M−152% from $8.8M in FY 201110-K cash flow statement, on EDGAR

Get an email when Epocrates files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (7374) and public float not reported.

Data on this page was fetched . The filing on SEC.gov is the record.